Theragnostic imaging for radiation oncology: Dose-painting by numbers

Lancet Oncology

Volumn 6, Issue 2, 2005, Pages 112-117

  Bentzen, Søren M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 NITROIMIDAZOLE DERIVATIVE; 3' FLUOROTHYMIDINE F 18; 4,9 DIAZA 3,3,10,10 TETRAMETHYLDODECAN 2,11 DIONE DIOXIME TC 99M; BETA DEXTRO IODOAZOMYCIN GALACTOPYRANOSIDE; COPPER 62; CYCLIN D; DIACETYL BIS[N(4) METHYLTHIOSEMICARBAZONE]; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; IODINE 123; IODINE 125; IODOAZOMYCIN ARABINOSIDE; KI 67 ANTIGEN; MISONIDAZOLE; PIMONIDAZOLE; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; SEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

BEAM THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CLONOGENESIS; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DOSIMETRY; DRUG MECHANISM; HUMAN; HYPOXEMIA; INTENSITY MODULATED RADIATION THERAPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOLOGY; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRESCRIPTION; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 13344277921     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(05)01737-7     Document Type: Note

References (39)

1. Weissleder R. Molecular imaging: Exploring the next frontier Radiology 212 1999 609-614
2. Herschman HR. Molecular imaging: Looking at problems, seeing solutions Science 302 2003 605-608
3. Intensity Modulated Radiation Therapy Collaborative Working Group Intensity-modulated radiotherapy: Current status and issues of interest Int J Radiat Oncol Biol Phys 51 2001 880-914
4. Bentzen SM. High-tech in radiation oncology: Should there be a ceiling? Int J Radiat Oncol Biol Phys 58 2004 320-330
5. Garcia-Segura JM Sanchez-Chapado M Ibarburen C et al. In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology Magn Reson Imaging 17 1999 755-765
6. Zelefsky MJ Cohen G Zakian KL et al. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging Cancer J 6 2000 249-255
7. Bos R Der Hoeven JJ van Der WE et al. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography J Clin Oncol 20 2002 379-387
8. Nordsmark M Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy Radiother Oncol 57 2000 39-43
9. Harris AL. Hypoxia: A key regulatory factor in tumour growth Nat Rev Cancer 2 2002 38-47
10. Chapman JD Bradley JD Eary JF et al. Molecular (functional) imaging for radiotherapy applications: An RTOG symposium Int J Radiat Oncol Biol Phys 55 2003 294-301
11. Padhani AR Husband JE. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies Clin Radiol 56 2001 607-620
12. Taylor NJ Baddeley H Goodchild KA et al. BOLD MRI of human tumor oxygenation during carbogen breathing J Magn Reson Imaging 14 2001 156-163
13. Serganova I Doubrovin M Vider J et al. Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice Cancer Res 64 2004 6101-6108
14. Bernier J Bentzen SM. Altered fractionation and combined radio-chemotherapy approaches: Pioneering new opportunities in head and neck oncology Eur J Cancer 39 2003 560-571
15. Overgaard J Hansen HS Specht L et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial Lancet 362 2003 933-940
16. Bentzen SM. Repopulation in radiation oncology: Perspectives of clinical research Int J Radiat Biol 79 2003 581-585
17. Van de Wiele C Lahorte C Oyen W et al. Nuclear medicine imaging to predict response to radiotherapy: A review Int J Radiat Oncol Biol Phys 55 2003 5-15
18. Shields AF Grierson JR Dohmen BM et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography Nat Med 4 1998 1334-1336
19. Buck AK Schirrmeister H Hetzel M et al. 3-deoxy-3-[(18)F] fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules Cancer Res 62 2002 3331-3334
20. Vesselle H Grierson J Muzi M et al. In vivo validation of 39deoxy-39- [(18)F]-fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: Correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors Clin Cancer Res 8 2002 3315-3323
21. Lu L Samuelsson L Bergstrom M et al. Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as proliferation markers J Nucl Med 43 2002 1688-1698
22. Ang KK Berkey BA Tu X et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 62 2002 7350-7356
23. Eriksen JG Steiniche T Askaa J et al. The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck Int J Radiat Oncol Biol Phys 58 2004 561-566
24. Ramos-Suzarte M Rodriguez N Oliva JP et al. 99mTc-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin, part III: Clinical trials safety and diagnostic efficacy J Nucl Med 40 1999 768-775
25. Mishani E Abourbeh G Rozen Y et al. Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl] -amides: Potential PET bioprobes for molecular imaging of EGFR-positive tumors Nucl Med Biol 31 2004 469-476
26. Divgi CR Welt S Kris M et al. Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma J Natl Cancer Inst 83 1991 97-104
27. Buffa FM Bentzen SM Daley FM et al. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy Clin Cancer Res 10 2004 3745-3754
28. Seppenwoolde Y Engelsman M De Jaeger K et al. Optimizing radiation treatment plans for lung cancer using lung perfusion information Radiother Oncol 63 2002 165-177
29. Ling CC Humm J Larson S et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality Int J Radiat Oncol Biol Phys 47 2000 551-560
30. Chao KS Bosch WR Mutic S et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy Int J Radiat Oncol Biol Phys 49 2001 1171-1182
31. Bentzen SM Baumann M. The linear-quadratic model in clinical practice. In: Steel GG (Ed.), Basic clinical radiobiology 3rd edn 2002 134-146 Arnold London
32. Parker C Milosevic M Toi A et al. Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer Int J Radiat Oncol Biol Phys 58 2004 750-757
33. Alber M Paulsen F Eschmann SM Machulla HJ. On biologically conformal boost dose optimization Phys Med Biol 48 2003 N31-N35
34. Low DA. Quality assurance of intensity-modulated radiotherapy Semin Radiat Oncol 12 2002 219-228
35. McNair HA Adams EJ Clark CH et al. Implementation of IMRT in the radiotherapy department Br J Radiol 76 2003 850-856
36. Boehmer D Bohsung J Eichwurzel I et al. Clinical and physical quality assurance for intensity modulated radiotherapy of prostate cancer Radiother Oncol 71 2004 319-325
37. Hall EJ Wuu CS. Radiation-induced second cancers: The impact of 3D-CRT and IMRT Int J Radiat Oncol Biol Phys 56 2003 83-88
38. Chaplin DJ Durand RE Olive PL. Acute hypoxia in tumors: Implications for modifiers of radiation effects Int J Radiat Oncol Biol Phys 12 1986 1279-1282
39. Dewhirst MW Kimura H Rehmus SW et al. Microvascular studies on the origins of perfusion-limited hypoxia Br J Cancer Suppl 27 1996 S247-S251